NDC 72934-1065

DAPSONE 8.5% / NIACINAMIDE 2% / TRETINOIN 0.025%

Dapsone 8.5% / Niacinamide 2% / Tretinoin 0.025%

DAPSONE 8.5% / NIACINAMIDE 2% / TRETINOIN 0.025% is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida Llc. The primary component is Dapsone; Tretinoin; Niacinamide.

Product ID72934-1065_87ed8125-8403-5d53-e053-2995a90a6516
NDC72934-1065
Product TypeHuman Prescription Drug
Proprietary NameDAPSONE 8.5% / NIACINAMIDE 2% / TRETINOIN 0.025%
Generic NameDapsone 8.5% / Niacinamide 2% / Tretinoin 0.025%
Dosage FormGel
Route of AdministrationTOPICAL
Marketing Start Date2019-05-03
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameSincerus Florida LLC
Substance NameDAPSONE; TRETINOIN; NIACINAMIDE
Active Ingredient Strength9 g/100g; g/100g; g/100g
Pharm ClassesSulfone [EPC],Sulfones [CS],Retinoid [EPC],Retinoids [CS]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 72934-1065-2

30 g in 1 BOTTLE, PUMP (72934-1065-2)
Marketing Start Date2019-05-03
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72934-1065-2 [72934106502]

DAPSONE 8.5% / NIACINAMIDE 2% / TRETINOIN 0.025% GEL
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-05-03

Drug Details

Active Ingredients

IngredientStrength
DAPSONE8.5 g/100g

Pharmacological Class

  • Sulfone [EPC]
  • Sulfones [CS]
  • Retinoid [EPC]
  • Retinoids [CS]
  • Sulfone [EPC]
  • Sulfones [CS]
  • Retinoid [EPC]
  • Retinoids [CS]

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.